Table 1.
Characteristics of 9,431 Medicare Beneficiaries that Ever Used Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 1999-2003
| Mean or n | Standard Deviation or (%) | |
|---|---|---|
| Demographics | ||
| Age | 71.51 | 13.36 |
| Race | ||
| White | 7,764 | 82.3% |
| Black | 1,093 | 11.6% |
| Other Race | 537 | 5.7% |
| Education | ||
| Lower than high school | 2,905 | 30.8% |
| High school | 2,192 | 23.2% |
| Higher than high school | 2,760 | 29.3% |
| Gender | ||
| Male | 3,586 | 38.0% |
| Female | 5,845 | 62.0% |
| Income ($/year) | 25,192 | 41,095 |
| Clinical Characteristics | ||
| Body Mass Index | ||
| BMI < 25 | 3,342 | 35.8% |
| 25 =<BMI <=30 | 3,374 | 36.2% |
| BMI > 30 | 2,618 | 28.1% |
| Tobacco Use | ||
| Smoke Now | 1,312 | 24.4% |
| No smoking now | 4,065 | 75.6% |
| Comorbidities | ||
| Old MI | ||
| Yes | 117 | 1.2% |
| No | 9,314 | 98.8% |
| Coronary artery disease | ||
| Yes | 938 | 14.3% |
| No | 8,493 | 85.7% |
| Hypertension | ||
| Yes | 2,268 | 24.0% |
| No | 7,163 | 76.0% |
| Diabetes | ||
| Yes | 949 | 10.1% |
| No | 8,482 | 89.9% |
| Hyperlipidemia | ||
| Yes | 1,288 | 13.7% |
| No | 8,143 | 86.3% |
| Renal Failure | ||
| Yes | 152 | 1.6% |
| No | 9,279 | 98.4% |
| COPD | ||
| Yes | 411 | 4.4% |
| No | 9,020 | 95.6% |
| Had PTCA | ||
| Yes | 31 | 0.3% |
| No | 9,400 | 99.7% |
| Had CABG | ||
| Yes | 33 | 0.4% |
| No | 9,398 | 99.6% |
| Charlson comorbidity index | 0.25 | 0.70 |
| NSAIDs used during study period** | ||
| Celecoxib | 3,018 | 32.0% |
| Rofecoxib | 2,255 | 23.9% |
| Valdecoxib | 193 | 2.1% |
| Other Ns aid | 5,278 | 56.0% |
**
total sums to more than 100% since persons may have used more than one NSAID